SKBioscience is also accelerating the development of new concept biopharmaceuticals following vaccines. ‘Next Pandemic’announced that they would prepare.
SKBioscience injects antiviral protein into nasal cavity19 Developing medicines to prevent infections such as viruses.
This project is&Through research and development funds supported by the Melinda Gates Foundation,IAVI (International AIDS Vaccine Promotion Headquarters) and IPD(Institute of Antigen Design, University of Washington) overseas research institutes are collaborating.
Candidates for this project are ‘nasal spray(Nasal Spray)’ corona in a way19 It is characterized by being able to quickly and conveniently use it for quarantine in a situation where the virus is rapidly spreading.. In the case of nasal injection, it forms a protective film inside the nose to prevent the virus from penetrating into our body. A small-scale protein disrupts the virus penetration to prevent infection.
Nasal spray can be widely applied to various infectious diseases and can have therapeutic effects as well as prevention. 2020year 9monthly international journal ‘science’It was published in the.
SKWhen a product is commercialized, bioscience, Like the mask that played the most important role in preventing the spread of this pandemic,, Preventing the spread of the virus preemptively before a vaccine or treatment is developed 1It is expected to serve as a car defense line..
for this project BMGFIs IAVIsupport R&D expenses to SKBioscience is a double drug 220just USdollar(Hanwha Medicine 26.5billion won)cast IAVIReceive preferential support for initial non-clinical development expenses from. SKBioscience will use this amount for initial process research for the discovery and production of candidate materials..
this study SKLeading the way with bioscience IPDof David Baker(David Baker) He is a professor of biochemistry at Washington University of Pharmacy. 500Publication of more than two papers and 100We have a splendid history of patent approvals, etc.. A world authority in the field of protein design research is currently in the process of developing candidate materials for this project and conducting animal experiments..
SKbioscience is IAVI, IPDTogether with the company, the company plans to broadly expand the scope of application by establishing a nasal spray as a platform for pharmaceuticals for the prevention and treatment of respiratory viruses..
SKAhn Jae-yong, president of Bioscience “If it is possible to secure a differentiated viral infection prevention and treatment through this study,, Rapid response to continuously evolving respiratory viruses will be possible”saying “Our efforts to develop medicines that can prevent and treat viruses that are a threat to mankind are leading to various international cooperation., because of this SKBioscience is also evolving into a global company”said.
MeanwhileSKbioscience is BMGFunder the support of 2013year IVI(International Vaccine Research Institute)After developing a typhoid conjugate vaccine and confirming its excellent level of immunogenicity and safety, it has completed an application for product approval to the Ministry of Food and Drug Safety..